Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Policy Priorities and COVID-19

May 11, 2020/Podcast

APTA staff Justin Elliott and Kara Gainer, JD, discuss what’s happening in Congress, what’s to come, and what APTA is doing to advocate on behalf of the profession. 

Resources for PT and PTA Students

APTA offers numerous opportunities to get involved and provides resources to support you now and into your career.

Sharing My Voice and Enthusiasm as a Student

Jul 30, 2019/Perspective

I've never been in a room with so many strangers and felt perfectly at home and a sincere sense of belonging.

Consumer Protection Through Licensure of Physical Therapists and Physical Therapist Assistants

Oct 1, 2025/Policies & Bylaws

House position: Consumer Protection Through Licensure of Physical Therapists and Physical Therapist Assistants.

Physical and Chemical Restraints: Role of the Physical Therapist

Aug 30, 2018/Policies & Bylaws

House position: APTA recognizes that inappropriate or indiscriminate use of physical and chemical restraints across the life span is harmful to the quality of life of patients and clients.

Digital Health Technologies, Digital Therapeutics, and Artificial Intelligence in Physical Therapist Practice

Sep 23, 2024/Policies & Bylaws

House position: The association believes digital health technologies, digital therapeutics, and AI have the potential to augment physical therapist practice.

Digital Health Technology and Physical Therapy

Apr 15, 2022/Statement

APTA maintains that "physical therapy," whether provided in person or virtually, is performed or directed by licensed physical therapists.

American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

Mar 31, 2015/CPG

The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.

American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Fascioscapulohumeral Muscular Dystrophy

Jul 28, 2015/CPG

Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.

APTA Launches Online Community to Foster Member Connection and Collaboration

Jul 28, 2025/News

APTA’s new online community offers members a dynamic space for discussion, collaboration, and innovation.